The proportion of hormone receptor-positive breast cancers increases with age and is considered as the more favorable tumor biology, since hormone receptor-positive tumors tend to grow more slowly and frequently respond to hormonal therapy. This evidence concerns the gene NR4A1 and breast carcinoma.